Sanj K. Patel - CHAIRMAN & CEO, Director at Kiniksa Pharmaceuticals International, plc

Insider Transactions and Holdings

Entity Type
Individual
Role
CHAIRMAN & CEO, Director
Issuer Symbol
KNSA on Nasdaq
All Insider Reports
All Insider Reports

Sanj K. Patel - trading volume in the past year for Kiniksa Pharmaceuticals International, plc

Holdings reported by Sanj K. Patel for Kiniksa Pharmaceuticals International, plc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Ordinary Share 109,795 $4,263,339 $38.83 12 Nov 2025 Held by The Marina 2016 Irrevocable Trust
Class A Ordinary Share 60,000 $2,329,800 $38.83 13 Nov 2025 Held by The Patel Family Irrevocable Trust of 2025
Class A Ordinary Share 51,794 $2,011,161 $38.83 13 Nov 2025 Held by The Anglia 2013 Revocable Trust
Performance Share Unit 8,386 $1,231,378 $17.88 01 May 2025 Direct Class A Ordinary Share
Class A Ordinary Share 0 $0 $38.83 12 Nov 2025 Direct
Performance Share Option 26,238 01 May 2025 Direct Class A Ordinary Share
Restricted Share Unit 0 02 Sep 2025 Direct Class A Ordinary Share
Share Option 0 22 Oct 2025 Direct Class A Ordinary Share

Transactions reported by Sanj K. Patel for Kiniksa Pharmaceuticals International, plc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.